OREANDA-NEWS. June 1, 2012. "Grindeks" participates in the conference “CEO Meets Investor”, organized by “NASDAQ OMX Baltic”, held in Vilnius, Lithuania. During the conference, "Grindeks" Chief Finance and Administrative Officer Vadims Rabsa will meet with investors and media representatives and inform on the company’s business model, the results and future strategies.

Over the past five years, "Grindeks", by investing more than 32 million lats, has made strategic investments in the business infrastructure development, in the establishment of new active pharmaceutical ingredients and final dosage form production units and other important projects. Thus, a world class pharmaceutical manufacturing infrastructure has been developed, which is an important advantage in the tough competition.

In his presentation, "Grindeks" Chief Finance and Administrative Officer Vadims Rabsa will inform on the market situation of final dosage forms and active pharmaceutical ingredients and will talk about "Grindeks" strategy of original products and generics and business development prospects in existing and new markets. (Please see the attached presentation).

"Grindeks" Chief Finance and Administrative Officer Vadims Rabsa: “We have all the prerequisites - a modern infrastructure, abundant knowledge and extensive experience in the pharmaceutical business. Right now, in the pharmaceutical industry competition is becoming increasingly fierce. "Grindeks" will more and more purposefully use its potential. Our main task is to investigate the patient and client needs and to create offer by expanding the product range.”

“NASDAQ OMX Vilnius” annually organizes a conference for investors, which brings together the representatives of the Baltic States companies and wide range of investors.